Abstract
Haemophilus influenzae type b (Hib) is now recognized as an important pathogen in Asia. To evaluate disease susceptibility, and as a marker of Hib transmission before routine immunization was introduced in Kathmandu, 71 participants aged 7 months-77 years were recruited and 15 cord blood samples were collected for analysis of anti-polyribosylribitol phosphate antibody levels by enzyme-linked immunosorbent assay. Only 20% of children under 5 years old had levels considered protective (>0.15 µg/ml), rising to 83% of 15-54 year-olds. Prior to introduction of Hib vaccine in Kathmandu, the majority of young children were susceptible to disease.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Antibodies, Bacterial / blood
-
Antibodies, Bacterial / immunology
-
Bacterial Capsules / immunology*
-
Child
-
Child, Preschool
-
Enzyme-Linked Immunosorbent Assay
-
Haemophilus Infections / epidemiology
-
Haemophilus Infections / immunology*
-
Haemophilus Infections / microbiology
-
Haemophilus Vaccines / immunology*
-
Haemophilus influenzae type b / immunology*
-
Haemophilus influenzae type b / physiology
-
Host-Pathogen Interactions / immunology
-
Humans
-
Immunization Programs / methods*
-
Infant
-
Middle Aged
-
Nepal / epidemiology
-
Polysaccharides / immunology
-
Polysaccharides, Bacterial / immunology
-
Seroepidemiologic Studies
-
Vaccination / methods
-
Young Adult
Substances
-
Antibodies, Bacterial
-
Haemophilus Vaccines
-
Haemophilus influenzae type b polysaccharide vaccine
-
Polysaccharides
-
Polysaccharides, Bacterial
-
polyribitol phosphate
Grants and funding
This project was funded by the Oxford Vaccine Group (
www.ovg.ox.ac.uk) with support from the NIHR Oxford Biomedical Research Centre (BRC) (
http://oxfordbrc.nihr.ac.uk). A.S.P. was funded by a Rhodes Scholarship. D.F.K. receives salary support from the NIHR BRC. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.